nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—Clonus—Cisplatin—esophageal cancer	0.0526	0.0811	CcSEcCtD
Atropine—Temperature intolerance—Capecitabine—esophageal cancer	0.0272	0.042	CcSEcCtD
Atropine—Atrial arrhythmia—Capecitabine—esophageal cancer	0.0161	0.0248	CcSEcCtD
Atropine—Speech impairment NOS—Methotrexate—esophageal cancer	0.0152	0.0235	CcSEcCtD
Atropine—Scab—Capecitabine—esophageal cancer	0.0141	0.0217	CcSEcCtD
Atropine—Slurred speech—Cisplatin—esophageal cancer	0.0136	0.0209	CcSEcCtD
Atropine—Arrhythmia supraventricular—Capecitabine—esophageal cancer	0.0115	0.0178	CcSEcCtD
Atropine—Sinus tachycardia—Capecitabine—esophageal cancer	0.0111	0.0171	CcSEcCtD
Atropine—Blindness—Cisplatin—esophageal cancer	0.011	0.0169	CcSEcCtD
Atropine—Rash macular—Capecitabine—esophageal cancer	0.0109	0.0168	CcSEcCtD
Atropine—Ileus paralytic—Capecitabine—esophageal cancer	0.0103	0.0159	CcSEcCtD
Atropine—Balance disorder—Capecitabine—esophageal cancer	0.00818	0.0126	CcSEcCtD
Atropine—Visual acuity reduced—Capecitabine—esophageal cancer	0.00752	0.0116	CcSEcCtD
Atropine—Ageusia—Cisplatin—esophageal cancer	0.00749	0.0115	CcSEcCtD
Atropine—Loss of libido—Methotrexate—esophageal cancer	0.00721	0.0111	CcSEcCtD
Atropine—Keratitis—Capecitabine—esophageal cancer	0.00689	0.0106	CcSEcCtD
Atropine—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.00682	0.0105	CcSEcCtD
Atropine—Haemoglobin decreased—Capecitabine—esophageal cancer	0.0065	0.01	CcSEcCtD
Atropine—Dysarthria—Cisplatin—esophageal cancer	0.00641	0.00988	CcSEcCtD
Atropine—Pain—Carboplatin—esophageal cancer	0.00631	0.00972	CcSEcCtD
Atropine—Laryngitis—Capecitabine—esophageal cancer	0.0062	0.00956	CcSEcCtD
Atropine—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00584	0.009	CcSEcCtD
Atropine—Rash erythematous—Capecitabine—esophageal cancer	0.00584	0.009	CcSEcCtD
Atropine—Body temperature increased—Carboplatin—esophageal cancer	0.00583	0.00899	CcSEcCtD
Atropine—Skin exfoliation—Cisplatin—esophageal cancer	0.00579	0.00892	CcSEcCtD
Atropine—Ageusia—Capecitabine—esophageal cancer	0.00552	0.0085	CcSEcCtD
Atropine—Petechiae—Capecitabine—esophageal cancer	0.00543	0.00837	CcSEcCtD
Atropine—Extrasystoles—Capecitabine—esophageal cancer	0.00531	0.00819	CcSEcCtD
Atropine—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00495	0.00763	CcSEcCtD
Atropine—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00495	0.00763	CcSEcCtD
Atropine—Nasal congestion—Cisplatin—esophageal cancer	0.00483	0.00745	CcSEcCtD
Atropine—Paralysis—Methotrexate—esophageal cancer	0.00479	0.00738	CcSEcCtD
Atropine—Dysarthria—Capecitabine—esophageal cancer	0.00473	0.00728	CcSEcCtD
Atropine—Cyanosis—Methotrexate—esophageal cancer	0.0047	0.00725	CcSEcCtD
Atropine—Amnesia—Cisplatin—esophageal cancer	0.00469	0.00722	CcSEcCtD
Atropine—Blood pressure increased—Capecitabine—esophageal cancer	0.00447	0.00689	CcSEcCtD
Atropine—Stupor—Methotrexate—esophageal cancer	0.00446	0.00687	CcSEcCtD
Atropine—Injection site reaction—Capecitabine—esophageal cancer	0.00444	0.00685	CcSEcCtD
Atropine—Hyponatraemia—Cisplatin—esophageal cancer	0.00442	0.00681	CcSEcCtD
Atropine—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00432	0.00665	CcSEcCtD
Atropine—Skin exfoliation—Capecitabine—esophageal cancer	0.00427	0.00658	CcSEcCtD
Atropine—Irritability—Cisplatin—esophageal cancer	0.0042	0.00648	CcSEcCtD
Atropine—Dry eye—Capecitabine—esophageal cancer	0.00413	0.00636	CcSEcCtD
Atropine—Dehydration—Cisplatin—esophageal cancer	0.00409	0.00631	CcSEcCtD
Atropine—Petechiae—Methotrexate—esophageal cancer	0.00404	0.00623	CcSEcCtD
Atropine—Hypokalaemia—Cisplatin—esophageal cancer	0.00401	0.00617	CcSEcCtD
Atropine—Speech disorder—Methotrexate—esophageal cancer	0.00387	0.00596	CcSEcCtD
Atropine—Swelling—Capecitabine—esophageal cancer	0.00368	0.00567	CcSEcCtD
Atropine—Eye pain—Capecitabine—esophageal cancer	0.00359	0.00554	CcSEcCtD
Atropine—Dysarthria—Methotrexate—esophageal cancer	0.00352	0.00542	CcSEcCtD
Atropine—Amnesia—Capecitabine—esophageal cancer	0.00345	0.00532	CcSEcCtD
Atropine—Atrial fibrillation—Capecitabine—esophageal cancer	0.00342	0.00528	CcSEcCtD
Atropine—Thirst—Capecitabine—esophageal cancer	0.00341	0.00525	CcSEcCtD
Atropine—Respiratory failure—Methotrexate—esophageal cancer	0.00339	0.00522	CcSEcCtD
Atropine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00334	0.00515	CcSEcCtD
Atropine—Myocardial infarction—Cisplatin—esophageal cancer	0.00333	0.00512	CcSEcCtD
Atropine—Lethargy—Capecitabine—esophageal cancer	0.00331	0.0051	CcSEcCtD
Atropine—Conjunctivitis—Cisplatin—esophageal cancer	0.0033	0.00508	CcSEcCtD
Atropine—Hyponatraemia—Capecitabine—esophageal cancer	0.00326	0.00502	CcSEcCtD
Atropine—Osteoarthritis—Capecitabine—esophageal cancer	0.00324	0.005	CcSEcCtD
Atropine—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00321	0.00495	CcSEcCtD
Atropine—Skin exfoliation—Methotrexate—esophageal cancer	0.00318	0.0049	CcSEcCtD
Atropine—Bradycardia—Cisplatin—esophageal cancer	0.0031	0.00478	CcSEcCtD
Atropine—Irritability—Capecitabine—esophageal cancer	0.0031	0.00477	CcSEcCtD
Atropine—Urinary retention—Capecitabine—esophageal cancer	0.00309	0.00476	CcSEcCtD
Atropine—Cardiac arrest—Capecitabine—esophageal cancer	0.00309	0.00476	CcSEcCtD
Atropine—Ataxia—Capecitabine—esophageal cancer	0.00305	0.0047	CcSEcCtD
Atropine—Coma—Methotrexate—esophageal cancer	0.00304	0.00469	CcSEcCtD
Atropine—Dehydration—Capecitabine—esophageal cancer	0.00302	0.00465	CcSEcCtD
Atropine—Dry skin—Capecitabine—esophageal cancer	0.00297	0.00458	CcSEcCtD
Atropine—Pulmonary oedema—Methotrexate—esophageal cancer	0.00296	0.00456	CcSEcCtD
Atropine—Hypokalaemia—Capecitabine—esophageal cancer	0.00295	0.00455	CcSEcCtD
Atropine—Flushing—Cisplatin—esophageal cancer	0.00283	0.00436	CcSEcCtD
Atropine—Abdominal distension—Capecitabine—esophageal cancer	0.00282	0.00435	CcSEcCtD
Atropine—Dysphagia—Capecitabine—esophageal cancer	0.0028	0.00432	CcSEcCtD
Atropine—Angina pectoris—Capecitabine—esophageal cancer	0.00273	0.00421	CcSEcCtD
Atropine—Arrhythmia—Cisplatin—esophageal cancer	0.00272	0.00419	CcSEcCtD
Atropine—Erythema—Cisplatin—esophageal cancer	0.00265	0.00409	CcSEcCtD
Atropine—Dysuria—Capecitabine—esophageal cancer	0.00262	0.00404	CcSEcCtD
Atropine—Hyperglycaemia—Capecitabine—esophageal cancer	0.00253	0.0039	CcSEcCtD
Atropine—Vision blurred—Cisplatin—esophageal cancer	0.0025	0.00385	CcSEcCtD
Atropine—Depression—Capecitabine—esophageal cancer	0.00249	0.00384	CcSEcCtD
Atropine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00247	0.0038	CcSEcCtD
Atropine—Lethargy—Methotrexate—esophageal cancer	0.00247	0.0038	CcSEcCtD
Atropine—Myocardial infarction—Capecitabine—esophageal cancer	0.00245	0.00378	CcSEcCtD
Atropine—Conjunctivitis—Capecitabine—esophageal cancer	0.00243	0.00375	CcSEcCtD
Atropine—Osteoarthritis—Methotrexate—esophageal cancer	0.00242	0.00372	CcSEcCtD
Atropine—Irritability—Methotrexate—esophageal cancer	0.00231	0.00355	CcSEcCtD
Atropine—Convulsion—Cisplatin—esophageal cancer	0.0023	0.00354	CcSEcCtD
Atropine—Bradycardia—Capecitabine—esophageal cancer	0.00229	0.00352	CcSEcCtD
Atropine—Ataxia—Methotrexate—esophageal cancer	0.00227	0.0035	CcSEcCtD
Atropine—Anxiety—Cisplatin—esophageal cancer	0.00225	0.00347	CcSEcCtD
Atropine—Oedema—Cisplatin—esophageal cancer	0.00216	0.00333	CcSEcCtD
Atropine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00216	0.00333	CcSEcCtD
Atropine—Tachycardia—Cisplatin—esophageal cancer	0.00211	0.00325	CcSEcCtD
Atropine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00209	0.00322	CcSEcCtD
Atropine—Flushing—Capecitabine—esophageal cancer	0.00208	0.00321	CcSEcCtD
Atropine—Hypotension—Cisplatin—esophageal cancer	0.00202	0.00312	CcSEcCtD
Atropine—Arrhythmia—Capecitabine—esophageal cancer	0.00201	0.00309	CcSEcCtD
Atropine—Mental disorder—Capecitabine—esophageal cancer	0.00197	0.00303	CcSEcCtD
Atropine—Erythema—Capecitabine—esophageal cancer	0.00195	0.00301	CcSEcCtD
Atropine—Dysuria—Methotrexate—esophageal cancer	0.00195	0.00301	CcSEcCtD
Atropine—Dyspnoea—Cisplatin—esophageal cancer	0.00193	0.00297	CcSEcCtD
Atropine—Erectile dysfunction—Methotrexate—esophageal cancer	0.00192	0.00296	CcSEcCtD
Atropine—Dysgeusia—Capecitabine—esophageal cancer	0.00191	0.00295	CcSEcCtD
Atropine—Drowsiness—Methotrexate—esophageal cancer	0.00186	0.00287	CcSEcCtD
Atropine—Depression—Methotrexate—esophageal cancer	0.00186	0.00286	CcSEcCtD
Atropine—Pain—Cisplatin—esophageal cancer	0.00185	0.00285	CcSEcCtD
Atropine—Vision blurred—Capecitabine—esophageal cancer	0.00184	0.00284	CcSEcCtD
Atropine—Conjunctivitis—Methotrexate—esophageal cancer	0.00181	0.00279	CcSEcCtD
Atropine—Sweating—Methotrexate—esophageal cancer	0.00178	0.00275	CcSEcCtD
Atropine—Feeling abnormal—Cisplatin—esophageal cancer	0.00178	0.00275	CcSEcCtD
Atropine—Vertigo—Capecitabine—esophageal cancer	0.00176	0.00271	CcSEcCtD
Atropine—Syncope—Capecitabine—esophageal cancer	0.00175	0.0027	CcSEcCtD
Atropine—Palpitations—Capecitabine—esophageal cancer	0.00173	0.00266	CcSEcCtD
Atropine—Loss of consciousness—Capecitabine—esophageal cancer	0.00172	0.00265	CcSEcCtD
Atropine—Body temperature increased—Cisplatin—esophageal cancer	0.00171	0.00264	CcSEcCtD
Atropine—Chest pain—Capecitabine—esophageal cancer	0.00166	0.00256	CcSEcCtD
Atropine—Anxiety—Capecitabine—esophageal cancer	0.00166	0.00256	CcSEcCtD
Atropine—Dry mouth—Capecitabine—esophageal cancer	0.00163	0.00251	CcSEcCtD
Atropine—Confusional state—Capecitabine—esophageal cancer	0.00161	0.00248	CcSEcCtD
Atropine—Oedema—Capecitabine—esophageal cancer	0.00159	0.00246	CcSEcCtD
Atropine—Hypersensitivity—Cisplatin—esophageal cancer	0.00159	0.00246	CcSEcCtD
Atropine—Shock—Capecitabine—esophageal cancer	0.00157	0.00242	CcSEcCtD
Atropine—Tachycardia—Capecitabine—esophageal cancer	0.00156	0.0024	CcSEcCtD
Atropine—Asthenia—Cisplatin—esophageal cancer	0.00155	0.00239	CcSEcCtD
Atropine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00154	0.00238	CcSEcCtD
Atropine—Hypotension—Capecitabine—esophageal cancer	0.00149	0.0023	CcSEcCtD
Atropine—Diarrhoea—Cisplatin—esophageal cancer	0.00148	0.00228	CcSEcCtD
Atropine—Mental disorder—Methotrexate—esophageal cancer	0.00146	0.00226	CcSEcCtD
Atropine—Erythema—Methotrexate—esophageal cancer	0.00145	0.00224	CcSEcCtD
Atropine—Insomnia—Capecitabine—esophageal cancer	0.00144	0.00222	CcSEcCtD
Atropine—Dysgeusia—Methotrexate—esophageal cancer	0.00142	0.0022	CcSEcCtD
Atropine—Dyspnoea—Capecitabine—esophageal cancer	0.00142	0.00219	CcSEcCtD
Atropine—Dyspepsia—Capecitabine—esophageal cancer	0.0014	0.00216	CcSEcCtD
Atropine—Vomiting—Cisplatin—esophageal cancer	0.00138	0.00212	CcSEcCtD
Atropine—Fatigue—Capecitabine—esophageal cancer	0.00138	0.00212	CcSEcCtD
Atropine—Vision blurred—Methotrexate—esophageal cancer	0.00137	0.00211	CcSEcCtD
Atropine—Rash—Cisplatin—esophageal cancer	0.00136	0.0021	CcSEcCtD
Atropine—Constipation—Capecitabine—esophageal cancer	0.00136	0.0021	CcSEcCtD
Atropine—Pain—Capecitabine—esophageal cancer	0.00136	0.0021	CcSEcCtD
Atropine—Dermatitis—Cisplatin—esophageal cancer	0.00136	0.0021	CcSEcCtD
Atropine—Feeling abnormal—Capecitabine—esophageal cancer	0.00131	0.00203	CcSEcCtD
Atropine—Vertigo—Methotrexate—esophageal cancer	0.00131	0.00201	CcSEcCtD
Atropine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.0013	0.00201	CcSEcCtD
Atropine—Nausea—Cisplatin—esophageal cancer	0.00129	0.00198	CcSEcCtD
Atropine—Urticaria—Capecitabine—esophageal cancer	0.00127	0.00195	CcSEcCtD
Atropine—Abdominal pain—Capecitabine—esophageal cancer	0.00126	0.00194	CcSEcCtD
Atropine—Body temperature increased—Capecitabine—esophageal cancer	0.00126	0.00194	CcSEcCtD
Atropine—Convulsion—Methotrexate—esophageal cancer	0.00126	0.00194	CcSEcCtD
Atropine—Chest pain—Methotrexate—esophageal cancer	0.00124	0.00191	CcSEcCtD
Atropine—Confusional state—Methotrexate—esophageal cancer	0.0012	0.00184	CcSEcCtD
Atropine—Anaphylactic shock—Methotrexate—esophageal cancer	0.00119	0.00183	CcSEcCtD
Atropine—Hypersensitivity—Capecitabine—esophageal cancer	0.00118	0.00181	CcSEcCtD
Atropine—Hyperhidrosis—Methotrexate—esophageal cancer	0.00115	0.00177	CcSEcCtD
Atropine—Asthenia—Capecitabine—esophageal cancer	0.00114	0.00176	CcSEcCtD
Atropine—Pruritus—Capecitabine—esophageal cancer	0.00113	0.00174	CcSEcCtD
Atropine—Hypotension—Methotrexate—esophageal cancer	0.00111	0.00171	CcSEcCtD
Atropine—Diarrhoea—Capecitabine—esophageal cancer	0.00109	0.00168	CcSEcCtD
Atropine—Insomnia—Methotrexate—esophageal cancer	0.00107	0.00165	CcSEcCtD
Atropine—Dyspnoea—Methotrexate—esophageal cancer	0.00106	0.00163	CcSEcCtD
Atropine—Somnolence—Methotrexate—esophageal cancer	0.00106	0.00163	CcSEcCtD
Atropine—Dizziness—Capecitabine—esophageal cancer	0.00105	0.00163	CcSEcCtD
Atropine—Dyspepsia—Methotrexate—esophageal cancer	0.00105	0.00161	CcSEcCtD
Atropine—Fatigue—Methotrexate—esophageal cancer	0.00102	0.00158	CcSEcCtD
Atropine—Pain—Methotrexate—esophageal cancer	0.00102	0.00156	CcSEcCtD
Atropine—Vomiting—Capecitabine—esophageal cancer	0.00101	0.00156	CcSEcCtD
Atropine—Rash—Capecitabine—esophageal cancer	0.00101	0.00155	CcSEcCtD
Atropine—Dermatitis—Capecitabine—esophageal cancer	0.001	0.00155	CcSEcCtD
Atropine—Headache—Capecitabine—esophageal cancer	0.000999	0.00154	CcSEcCtD
Atropine—Feeling abnormal—Methotrexate—esophageal cancer	0.000978	0.00151	CcSEcCtD
Atropine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000971	0.0015	CcSEcCtD
Atropine—Nausea—Capecitabine—esophageal cancer	0.000947	0.00146	CcSEcCtD
Atropine—Urticaria—Methotrexate—esophageal cancer	0.000943	0.00145	CcSEcCtD
Atropine—Abdominal pain—Methotrexate—esophageal cancer	0.000939	0.00145	CcSEcCtD
Atropine—Body temperature increased—Methotrexate—esophageal cancer	0.000939	0.00145	CcSEcCtD
Atropine—Hypersensitivity—Methotrexate—esophageal cancer	0.000875	0.00135	CcSEcCtD
Atropine—Asthenia—Methotrexate—esophageal cancer	0.000852	0.00131	CcSEcCtD
Atropine—Pruritus—Methotrexate—esophageal cancer	0.00084	0.00129	CcSEcCtD
Atropine—Diarrhoea—Methotrexate—esophageal cancer	0.000812	0.00125	CcSEcCtD
Atropine—Dizziness—Methotrexate—esophageal cancer	0.000785	0.00121	CcSEcCtD
Atropine—Vomiting—Methotrexate—esophageal cancer	0.000755	0.00116	CcSEcCtD
Atropine—Rash—Methotrexate—esophageal cancer	0.000749	0.00115	CcSEcCtD
Atropine—Dermatitis—Methotrexate—esophageal cancer	0.000748	0.00115	CcSEcCtD
Atropine—Headache—Methotrexate—esophageal cancer	0.000744	0.00115	CcSEcCtD
Atropine—Nausea—Methotrexate—esophageal cancer	0.000705	0.00109	CcSEcCtD
Atropine—CHRM1—GPCR downstream signaling—GHRL—esophageal cancer	0.000227	0.000647	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—GHRL—esophageal cancer	0.000227	0.000645	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ALOX15—esophageal cancer	0.000226	0.000642	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	0.000224	0.000639	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000224	0.000638	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—GNG7—esophageal cancer	0.000223	0.000635	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CSNK1A1—esophageal cancer	0.00022	0.000626	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CSNK1A1—esophageal cancer	0.000219	0.000624	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—XIAP—esophageal cancer	0.000218	0.000622	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—ANXA1—esophageal cancer	0.000218	0.00062	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—ANXA1—esophageal cancer	0.000217	0.000618	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000217	0.000618	CbGpPWpGaD
Atropine—CHRM3—Metabolism—GSTO1—esophageal cancer	0.000215	0.000613	CbGpPWpGaD
Atropine—CHRM3—Metabolism—TPI1—esophageal cancer	0.000215	0.000613	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	0.000215	0.000612	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—SST—esophageal cancer	0.000212	0.000603	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—SST—esophageal cancer	0.000211	0.000601	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—SST—esophageal cancer	0.000209	0.000595	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—XIAP—esophageal cancer	0.000209	0.000595	CbGpPWpGaD
Atropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000208	0.000594	CbGpPWpGaD
Atropine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000208	0.000592	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—GHRL—esophageal cancer	0.000206	0.000588	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CTNNA1—esophageal cancer	0.000206	0.000588	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ALDOB—esophageal cancer	0.000206	0.000588	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—GHRL—esophageal cancer	0.000206	0.000586	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PFN1—esophageal cancer	0.000206	0.000586	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CXCL2—esophageal cancer	0.000205	0.000584	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PFN1—esophageal cancer	0.000205	0.000584	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	0.000204	0.00058	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PFN1—esophageal cancer	0.000203	0.000578	CbGpPWpGaD
Atropine—CHRM1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000202	0.000576	CbGpPWpGaD
Atropine—CHRM3—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000202	0.000574	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000199	0.000567	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000199	0.000567	CbGpPWpGaD
Atropine—CHRM3—Metabolism—GAPDH—esophageal cancer	0.000199	0.000566	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CTNNA1—esophageal cancer	0.000198	0.000563	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CRABP1—esophageal cancer	0.000197	0.000561	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CXCL2—esophageal cancer	0.000196	0.00056	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PSME2—esophageal cancer	0.000192	0.000546	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PSME1—esophageal cancer	0.000192	0.000546	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ANXA1—esophageal cancer	0.000191	0.000543	CbGpPWpGaD
Atropine—CHRM3—Metabolism—GNG7—esophageal cancer	0.000187	0.000533	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SST—esophageal cancer	0.000186	0.000528	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ELMO1—esophageal cancer	0.000185	0.000526	CbGpPWpGaD
Atropine—CHRM1—Circadian rythm related genes—TP53—esophageal cancer	0.000185	0.000526	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ELMO1—esophageal cancer	0.000184	0.000524	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PSME2—esophageal cancer	0.000184	0.000523	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PSME1—esophageal cancer	0.000184	0.000523	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ANXA1—esophageal cancer	0.000183	0.00052	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	0.000182	0.000519	CbGpPWpGaD
Atropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000181	0.000515	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—GHRL—esophageal cancer	0.000181	0.000515	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NOTCH3—esophageal cancer	0.000181	0.000515	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	0.00018	0.000514	CbGpPWpGaD
Atropine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.00018	0.000514	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKAP13—esophageal cancer	0.00018	0.000512	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	0.000178	0.000507	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—FBXW7—esophageal cancer	0.000178	0.000507	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000178	0.000506	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SST—esophageal cancer	0.000178	0.000506	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ALDH2—esophageal cancer	0.000175	0.0005	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NOTCH3—esophageal cancer	0.000173	0.000493	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—GHRL—esophageal cancer	0.000173	0.000493	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—FBXW7—esophageal cancer	0.00017	0.000485	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CA1—esophageal cancer	0.000169	0.000482	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000169	0.000482	CbGpPWpGaD
Atropine—CHRM3—Metabolism—GSTT1—esophageal cancer	0.000167	0.000475	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000167	0.000474	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000166	0.000473	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	0.000165	0.00047	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CYP2A6—esophageal cancer	0.000165	0.00047	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	0.000165	0.000469	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000164	0.000468	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	0.000163	0.000464	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NOTCH2—esophageal cancer	0.000162	0.000462	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GNG7—esophageal cancer	0.000157	0.000447	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GNG7—esophageal cancer	0.000157	0.000446	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTGS1—esophageal cancer	0.000156	0.000445	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ENO1—esophageal cancer	0.000156	0.000445	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NOTCH2—esophageal cancer	0.000155	0.000442	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GNG7—esophageal cancer	0.000155	0.000441	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CA2—esophageal cancer	0.000155	0.000441	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PSME2—esophageal cancer	0.000154	0.000439	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PSME1—esophageal cancer	0.000154	0.000439	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000151	0.000431	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—XIAP—esophageal cancer	0.000147	0.000419	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—XIAP—esophageal cancer	0.000147	0.000418	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—XIAP—esophageal cancer	0.000145	0.000414	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TGFBR2—esophageal cancer	0.000144	0.00041	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ADH7—esophageal cancer	0.000144	0.00041	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PLCE1—esophageal cancer	0.000144	0.00041	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000142	0.000405	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	0.000139	0.000396	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	0.000139	0.000395	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	0.000138	0.000394	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	0.000138	0.000393	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TGFBR2—esophageal cancer	0.000138	0.000392	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	0.000137	0.000391	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	0.000137	0.000389	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SMAD4—esophageal cancer	0.000136	0.000388	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CYP1B1—esophageal cancer	0.000133	0.000379	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SMAD4—esophageal cancer	0.00013	0.000371	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PSME2—esophageal cancer	0.000129	0.000368	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PSME1—esophageal cancer	0.000129	0.000368	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PSME2—esophageal cancer	0.000129	0.000367	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PSME1—esophageal cancer	0.000129	0.000367	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	0.000129	0.000366	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	0.000128	0.000365	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PSME2—esophageal cancer	0.000128	0.000363	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PSME1—esophageal cancer	0.000128	0.000363	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	0.000127	0.000362	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ADH1B—esophageal cancer	0.000126	0.000359	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SST—esophageal cancer	0.000125	0.000356	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CYP19A1—esophageal cancer	0.000125	0.000356	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SST—esophageal cancer	0.000125	0.000355	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SST—esophageal cancer	0.000124	0.000352	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	0.000122	0.000347	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—GHRL—esophageal cancer	0.000122	0.000347	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	0.000122	0.000346	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—GHRL—esophageal cancer	0.000122	0.000346	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—TYMP—esophageal cancer	0.000121	0.000343	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	0.00012	0.000343	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—GHRL—esophageal cancer	0.00012	0.000343	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	0.00012	0.000342	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	0.00012	0.000341	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	0.000118	0.000337	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	0.000117	0.000334	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALOX15—esophageal cancer	0.000114	0.000325	CbGpPWpGaD
Atropine—CHRM3—Metabolism—HMOX1—esophageal cancer	0.000114	0.000325	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—HIF1A—esophageal cancer	0.000111	0.000317	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ABCB1—esophageal cancer	0.000109	0.000312	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	0.000109	0.000311	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	0.000109	0.00031	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTO1—esophageal cancer	0.000109	0.00031	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—TPI1—esophageal cancer	0.000109	0.00031	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	0.000108	0.000307	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HIF1A—esophageal cancer	0.000107	0.000304	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—KDR—esophageal cancer	0.000107	0.000304	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALDOB—esophageal cancer	0.000104	0.000298	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—KDR—esophageal cancer	0.000102	0.000291	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GAPDH—esophageal cancer	0.000101	0.000286	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NOTCH1—esophageal cancer	0.0001	0.000286	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CRABP1—esophageal cancer	9.97e-05	0.000284	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	9.7e-05	0.000276	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	9.67e-05	0.000275	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NOTCH1—esophageal cancer	9.61e-05	0.000274	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	9.58e-05	0.000273	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GNG7—esophageal cancer	9.48e-05	0.00027	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	9.18e-05	0.000262	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	9.15e-05	0.000261	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CREBBP—esophageal cancer	9.1e-05	0.000259	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	9.06e-05	0.000258	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—EGFR—esophageal cancer	8.94e-05	0.000255	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALDH2—esophageal cancer	8.89e-05	0.000253	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CREBBP—esophageal cancer	8.72e-05	0.000248	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—EGFR—esophageal cancer	8.57e-05	0.000244	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—PIK3CA—esophageal cancer	8.55e-05	0.000243	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTT1—esophageal cancer	8.45e-05	0.000241	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	8.35e-05	0.000238	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.32e-05	0.000237	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—PIK3CA—esophageal cancer	8.19e-05	0.000233	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NOS3—esophageal cancer	8.15e-05	0.000232	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTGS1—esophageal cancer	7.92e-05	0.000226	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ENO1—esophageal cancer	7.92e-05	0.000226	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NOS3—esophageal cancer	7.8e-05	0.000222	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PSME2—esophageal cancer	7.8e-05	0.000222	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PSME1—esophageal cancer	7.8e-05	0.000222	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—PIK3CA—esophageal cancer	7.76e-05	0.000221	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ERBB2—esophageal cancer	7.62e-05	0.000217	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	7.51e-05	0.000214	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	7.49e-05	0.000213	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—PIK3CA—esophageal cancer	7.43e-05	0.000212	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	7.42e-05	0.000211	CbGpPWpGaD
Atropine—CHRM3—Metabolism—CREBBP—esophageal cancer	7.32e-05	0.000208	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ERBB2—esophageal cancer	7.3e-05	0.000208	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KDR—esophageal cancer	7.19e-05	0.000205	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KDR—esophageal cancer	7.16e-05	0.000204	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KDR—esophageal cancer	7.09e-05	0.000202	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.81e-05	0.000194	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	6.77e-05	0.000193	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	6.75e-05	0.000192	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCND1—esophageal cancer	6.73e-05	0.000192	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	6.73e-05	0.000192	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	6.68e-05	0.00019	CbGpPWpGaD
Atropine—CHRM3—Metabolism—NOS3—esophageal cancer	6.55e-05	0.000187	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN1A—esophageal cancer	6.51e-05	0.000186	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCND1—esophageal cancer	6.45e-05	0.000184	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	6.33e-05	0.00018	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN1A—esophageal cancer	6.24e-05	0.000178	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—EP300—esophageal cancer	6.2e-05	0.000177	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	6.14e-05	0.000175	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	6.12e-05	0.000174	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	6.06e-05	0.000173	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	6.03e-05	0.000172	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	6.01e-05	0.000171	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTGS2—esophageal cancer	5.99e-05	0.000171	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	5.95e-05	0.00017	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—EP300—esophageal cancer	5.94e-05	0.000169	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HMOX1—esophageal cancer	5.78e-05	0.000165	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	5.76e-05	0.000164	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	5.75e-05	0.000164	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	5.69e-05	0.000162	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.67e-05	0.000161	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ABCB1—esophageal cancer	5.55e-05	0.000158	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOS3—esophageal cancer	5.49e-05	0.000157	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOS3—esophageal cancer	5.48e-05	0.000156	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOS3—esophageal cancer	5.42e-05	0.000154	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MYC—esophageal cancer	5.4e-05	0.000154	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—EGFR—esophageal cancer	5.28e-05	0.00015	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	5.23e-05	0.000149	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	5.22e-05	0.000149	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MYC—esophageal cancer	5.17e-05	0.000147	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	5.17e-05	0.000147	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	5.14e-05	0.000146	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	5.12e-05	0.000146	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	5.07e-05	0.000145	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—EGFR—esophageal cancer	5.06e-05	0.000144	CbGpPWpGaD
Atropine—CHRM3—Metabolism—EP300—esophageal cancer	4.98e-05	0.000142	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CA—esophageal cancer	4.59e-05	0.000131	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCND1—esophageal cancer	4.54e-05	0.000129	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCND1—esophageal cancer	4.53e-05	0.000129	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCND1—esophageal cancer	4.48e-05	0.000128	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TP53—esophageal cancer	4.44e-05	0.000126	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	4.39e-05	0.000125	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CA—esophageal cancer	4.39e-05	0.000125	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	4.38e-05	0.000125	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	4.34e-05	0.000124	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TP53—esophageal cancer	4.25e-05	0.000121	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.19e-05	0.000119	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EP300—esophageal cancer	4.18e-05	0.000119	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EP300—esophageal cancer	4.17e-05	0.000119	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EP300—esophageal cancer	4.13e-05	0.000118	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CREBBP—esophageal cancer	3.71e-05	0.000106	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CA—esophageal cancer	3.69e-05	0.000105	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MYC—esophageal cancer	3.64e-05	0.000104	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MYC—esophageal cancer	3.63e-05	0.000103	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MYC—esophageal cancer	3.6e-05	0.000102	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EGFR—esophageal cancer	3.56e-05	0.000101	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EGFR—esophageal cancer	3.55e-05	0.000101	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EGFR—esophageal cancer	3.52e-05	0.0001	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—NOS3—esophageal cancer	3.32e-05	9.45e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	3.09e-05	8.81e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	3.08e-05	8.78e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	3.05e-05	8.69e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.03e-05	8.64e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TP53—esophageal cancer	2.99e-05	8.52e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TP53—esophageal cancer	2.98e-05	8.49e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TP53—esophageal cancer	2.95e-05	8.41e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—EP300—esophageal cancer	2.52e-05	7.19e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.87e-05	5.32e-05	CbGpPWpGaD
